Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
MARKER FOR PREDICTING TUMOR REACTIVITY OF LYMPHOCYTES, AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2020/184911
Kind Code:
A1
Abstract:
The present invention relates to a marker for predicting tumor reactivity of lymphocytes, a composition for predicting tumor reactivity, and a method for predicting tumor reactivity. According to the present invention, a predictive model capable of predicting tumor reactivity of cultured lymphocytes can be constructed using a genetic marker, and through the predictive model, the reactivity of lymphocytes is predicted so as to more accurately select lymphocytes specific to a tumor and produce an effective immunotherapeutic agent. In addition, the use of the genetic marker enables lymphocytes to be separated more easily from tissues, blood, or body fluids in a body using non-invasive methods different from conventional invasive methods, and enables only lymphocytes with tumor-specific activity to be selected and used for immunotherapy. Therefore, the present invention is expected to have a wide range of applications.

Inventors:
LEE HEE JIN (KR)
GONG GYUNGYUB (KR)
LEE HEE JAE (KR)
SEO JEONG HAN (KR)
LIM GYEONGBACK (KR)
Application Number:
PCT/KR2020/003157
Publication Date:
September 17, 2020
Filing Date:
March 06, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ASAN FOUND (KR)
UNIV ULSAN FOUND IND COOP (KR)
International Classes:
C12Q1/6881; G01N33/569
Domestic Patent References:
WO2018032088A22018-02-22
Foreign References:
US20100310534A12010-12-09
US20170363629A12017-12-21
Other References:
BYUN KYUNG DO, HWANG HYO JUN, PARK KI JAE, KIM MIN CHAN, CHO SE HEON, JU MI HA, LEE JIN HWA, JEONG JIN SOOK: "T- Cell Immunoglobulin Mucin 3 Expression on Tumor Infiltrating Lymphocytes as a Positive Prognosticator in Triple-Negative Breast Cancer", J. BREAST CANCER, vol. 21, no. 4, December 2018 (2018-12-01), pages 406 - 414, XP055740574
VIKAS PRAVEEN, BORCHERDING NICHOLAS, ZHANG WEIZHOU: "The Clinical Promise of Immunotherapy in Triple-Negative Breast Cancer", CANCER MANAGEMENT AND RESEARCH, vol. 10, 2018, pages 6823 - 6833, XP055740578
SCIENCE, vol. 348, no. 6230, 3 April 2015 (2015-04-03), pages 62 - 8
Attorney, Agent or Firm:
ISIS IP LAW LLC (KR)
Download PDF: